Last reviewed · How we verify
NCT06750822: RESOLUTION
Accuracy of Automatic Contusion Volume Scanning for Predicting the Incidence of Pneumonia in Patients With Thoracic Trauma
trial in Pneumonia in 486 participants. Completed in 1 December 2024.
1 September 2024
Quick facts
| Lead sponsor | Azienda Usl di Bologna |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 486 |
| Start date | 1 May 2024 |
| Primary completion | 1 September 2024 |
| Estimated completion | 1 December 2024 |
| Sites | 1 location across Italy |
Conditions studied
- Pneumonia — all drugs for Pneumonia →
- Thoracic Trauma — all drugs for Thoracic Trauma →
Sponsor
Azienda Usl di Bologna — full company profile →
Who can join
18 and older, any sex, with Pneumonia or Thoracic Trauma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this retrospective observational study is to evaluate the diagnostic accuracy of pulmonary contusion volume in predicting early pneumonia in patients with thoracic trauma. The primary question we aim to answer is: What is the diagnostic accuracy of pulmonary contusion volume in predicting pneumonia within 7 days post-trauma? Moreover, we aim to explore which is the overlap between the contused segments and those developing pneumonia. Finally, we aim to explore relevant differences in radiomic features between contused segments that developed pneumonia.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Pulmonary contusion volume and radiomics as predictors of early-onset pneumonia in trauma patients, a retrospective single-centre study.
Gamberini L, Astuti GM, Biavati B, Boarato D, et al · · 2025 · PMID 40844714 · DOI 10.1007/s00068-025-02952-1
Verify or expand the search:
- PubMed search for NCT06750822
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pneumonia
Currently open trials in the same condition.
- NCT07453966 — Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mec · NA · recruiting
- NCT07251465 — A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia · active not recruiting
- NCT07311343 — Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia · Phase 4 · recruiting
- NCT07298889 — High PEEP in Noninvasive Ventilation Patients With Pneumonia or ARDS · NA · recruiting
- NCT06911658 — Infectious Complications After Esophagectomy · recruiting
Other Azienda Usl di Bologna trials
Trials by the same sponsor.
- NCT07492511 — Renal and Hepatic Abnormal Doppler Patterns in Trauma · recruiting
- NCT06742645 — The Use of Brief Motivational Interviewing in Community Health Centers. · NA · recruiting
- NCT06395558 — intErnet-based iNterventions FOR Cardiac arrEst suRvivors · NA · recruiting
- NCT06471231 — Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock · Phase 4 · recruiting
- NCT06586125 — Virtual Reality Impact on Powered Mobility: a Feasibility Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06750822 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Usl di Bologna
- Last refreshed: 27 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06750822.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing